Clinical trial Recruiting at 2 sites Interventional Ages 18 to 60

Motion Reset for preventing cybersickness during virtual reality

Official title: Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers

Run by National Institutes of Health Clinical Center (CC) · NCT06552754 · Data updated 2026-11-12

This project will test if Motion Reset software can reduce cybersickness in healthy adults using virtual reality.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment150 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations2 sites (Ames, Iowa and 1 other locations)
StatusRecruiting
StartedSeptember 26, 2025
Main results expectedFebruary 1, 2030
Study endsFebruary 1, 2030
Registry record updatedNovember 9, 2026
Trial IDNCT06552754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy English-speaking adults aged 18–60 with normal or corrected hearing and vision who are willing to use a VR headset are ideal candidates.

Probably not a fit

People who never experience motion sickness, those with extreme motion sickness propensity, or those who cannot participate in an in-person VR session may not receive benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy adults (ages 18–60) will have one clinic visit during which they learn to use a VR headset and complete self-report measures. Participants are randomized to an active Motion Reset intervention, a placebo VR experience, or a no-treatment control. After the assigned intervention they will play a VR game designed to induce moderate cybersickness while researchers collect symptom ratings before and after play and track how long participants tolerate the game. Participants may stop at any time or will be stopped if discomfort reaches a preset threshold.

Why it matters

Potential benefit: If successful, Motion Reset could reduce nausea, dizziness, headache, and eye strain from VR and make VR use more comfortable and longer-lasting.

How similar studies have gone: Previous sensory- or software-based approaches to reduce VR cybersickness have shown mixed or limited results, so this specific Motion Reset approach is relatively novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Aged 18-60
* Ability to read, speak, and write in English
* Normal or corrected-to-normal hearing
* Normal vision or corrected-to-normal without use of glasses. Contact lenses for corrective purposes are acceptable.

Ability to read, speak and write in English is a requirement because the VR-based study materials and assessment are only available in English and several of the key questionnaires for the study are not validated in other languages.

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

* Reporting motion sickness propensity of 0, 9 or 10 on a 0-10 scale where 0 =never experience motion sickness and 10 = experience motion sickness very frequently (self-assessed by participants).
* Reporting a history of photo-sensitive seizure disorders, vestibular disorders and/or other conditions that may make participants prone to nausea, dizziness, vertigo, ataxia, or incoordination.
* Known pregnancy
* Reporting current use of medication or supplements that inhibit nausea, e.g., Zofran/ondansetron, Phenergan/promethazine

Where it's running

  • Iowa State University
    Ames, Iowa, United States
    Recruiting
  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Susan J Persky, Ph.D. — National Human Genome Research Institute (NHGRI)
  • Study coordinator: Susan J Persky, Ph.D.
  • Email: NihVRStudy@nih.gov
  • Phone: (301) 451-1268

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.